Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)-Reference-Cited by-同舟云学术

Red Blood Cell Transfusion Dependence and Outcome after Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with de Novo Myelodysplastic Syndrome (MDS)

Published:2008-11 Issue:11 Volume:14 Page:1217-1225
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Platzbecker Uwe,Bornhäuser Martin,Germing Ulrich,Stumpf Julian,Scott Bart L.,Kröger Nicolaus,Schwerdtfeger Rainer,Böhm Alexandra,Kobbe Guido,Theuser Catrin,Rabitsch Werner,Valent Peter,Sorror Mohamed L.,Ehninger Gerhard,Deeg H. Joachim

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Azacitidine (AZA) treatment prolongs overall survival (OS) in higher-risk MDS patients compared with conventional care regimens (CCR): results of the AZA-001 phase III study;Fenaux;Blood,2007

2. Hemopoietic stem cell transplantation for myelodysplastic syndrome;Deeg;Curr Opin Oncol,2000

3. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome;Cutler;Blood,2004

4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

5. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making;Malcovati;J Clin Oncol,2005

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

2. Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Patients;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. The impact of pretransplant serum ferritin on haploidentical hematopoietic stem cell transplant for acquired severe aplastic anemia in children and adolescents;Pediatric Blood & Cancer;2022-06-30

4. Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients;Journal of Blood Medicine;2021-12

5. Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life;Frontiers in Pediatrics;2021-11-24